All Infection Prevention & Control articles – Page 5
-
NewsStudy uncovers new path toward fighting malaria
Researchers have discovered that the malaria parasite relies on a specific type of fat to survive and multiply within the human host, uncovering a previously unknown vulnerability that could help guide future treatments.
-
NewsAntibiotic-tolerant bacteria rely on a hidden survival strategy
Scientists have uncovered how S. pneumoniae adapts to antibiotic exposure and immune pressures. Their findings reveal that changes in RNA regulation enable bacteria to enter a state of antibiotic tolerance.
-
NewsMultidisciplinary framework bridges earth science and environmental engineering to combat waterborne pathogens
Waterborne pathogens remain a leading cause of infectious disease globally, responsible for 24% of all deaths and over 10 million fatalities each year. Source: Zheng-Yang Huo, et al. Graphic Abstract Despite decades of progress in water treatment, conventional approaches have struggled to keep pace with the evolving ...
-
NewsHow the most widespread parasite on earth reads its genome
Researchers have uncovered new details about how Toxoplasma controls the timing of protein production, ensuring the right molecular tools are available exactly when they are needed. Two protein complexes manage this process.
-
NewsResearchers find a new way to tackle drug-resistant infections - starvation
A drug designed to block ECF transporters would attack the bacteria while leaving human cells largely unaffected, substantially reducing the risk of side effects. A research team has succeeded in developing exactly such a drug candidate.
-
NewsResearchers develop automated system to accelerate outbreak detection and disease surveillance
Biomedical engineers have developed a fully automated workflow that simplifies and accelerates the preparation of bacterial samples for genetic sequencing. The method streamlines a critical bottleneck in the genetic sequencing process.
-
NewsCOVID-19 vaccines remain effective despite helminth-induced immune modulation
In a preclinical study, researchers have found that mRNA- and protein-based SARS-CoV-2 vaccines effectively protected Schistosoma-infected mice against the virus, despite the mice’s distinct immune response profiles.
-
NewsHow is climate change affecting waterborne diseases?
Researchers find bacteria, viruses and parasites respond differently to climate change, highlighting the need for pathogen-specific public health strategies.
-
NewsResearchers to tackle overlooked tropical disease
Two researchers are teaming up to build foundational knowledge concerning leishmaniasis, a common, but neglected protozoan parasitic disease. The project combines research into the cell biology of membrane repair with parasitology knowledge.
-
NewsNovel antifungal drug shows promise in some patients with Valley Fever
A study found that olorofim, a first-in-class orotomide antifungal agent, showed efficacy in patients with disseminated coccidioidomycosis (DCM), a rare complication of Valley Fever where the fungus spreads from the lungs to other parts of the body.
-
NewsMultisite test strip boosts mosquito-borne virus detection
A research team has developed a multisite bridging-mediated lateral flow immunoassay (mbLFIA) that enables highly sensitive, portable detection of mosquito-borne viruses, using Chikungunya virus (CHIKV) as a model target.
-
NewsAntivaccine legislation is rising rapidly in US states, driven primarily by GOP push
A new study revealed that Republican lawmakers were responsible for 86 per cent of antivaccine bills introduced across state legislatures after the onset of the COVID-19 pandemic, raising concerns about public health.
-
NewsWHO Member States continue negotiations on the Pathogen Access and Benefit Sharing Annex
WHO Member States have advanced negotiations on the Pathogen Access and Benefit Sharing (PABS) annex, while agreeing that continued discussions are needed to finalize a framework that supports a faster, more effective and equitable response to future pandemics.
-
News COVID-19 booster strategies provide lasting immunity
Smaller doses of COVID-19 booster vaccines can provide long-lasting immunity, helping to reduce costs and improve access to vaccination, according to research. The findings could also inform vaccine dosing and options during future pandemics.
-
NewsPartners launch development of a portable rapid diagnostic system for Ebola virus disease
Professor Yasutoshi Kido of the Graduate School of Medicine, Osaka Metropolitan University (OMU), in collaboration with K.K. DNAFORM and the National Institute for Biomedical Research (INRB) of the Democratic Republic of the Congo, is developing a portable rapid diagnostic system for Ebola virus disease (EVD) caused by Bundibugyo virus (BDBV). ...
-
NewsDrug-resistant gonorrhea on the rise in Europe, ECDC warns
An increasing number of European countries have detected gonococcal strains resistant to the antibiotic ceftriaxone, the first-line drug to treat gonorrhea infection.
-
NewsConnection between forests and rivers strengthens amphibians’ microbiome and protects them against a lethal fungus
A study indicates that a frog’s resistance to a fungus that has decimated hundreds of amphibian species worldwide is due not only to its genes, but also to the beneficial bacteria living on its skin and to the organization of its surrounding landscape.
-
NewsHow did the COVID-19 pandemic shift seasonal surges of other respiratory diseases?
A new analysis explores what underlies shifts in the timing of seasonal surges of respiratory diseases, as well as shifts in surges of heart-related deaths, that occurred after the COVID-19 pandemic began.
-
NewsAt-home, lab-quality HIV tests awarded $1.3 million for development
A new two-year, $1.3 million award will help researchers advance a proof-of-concept work toward commercialization of at-home HIV tests sensitive enough for early diagnosis comparable to—or exceeding—lab standards.
-
NewsResearch team receives $10 million NIH grant to study how animals fight infection
Researchers have built a collection of living cells from over 100 animal species to explore innate immune diversity. They have received a 5-year, $10 million grant to utilize this ‘cellular zoo’ to determine how diverse animals recognize and fight virus infections.